Research view
Switch to patient viewAsthma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- NLRP3 0
- IL-4 0
- MAPK 0
- PI3K 0
- TSLP 2
- STAT3 0
- AKT 0
- IL-13 0
- mTOR 0
- NRF2 0
- TNF 0
- TLR4 0
- GLP-1 0
- IL-17 0
- JAK 1
- PPAR 0
- HIF-1 0
- IL-6 0
- JNK 0
- AMPK 0
- ERK 0
- CD40 0
- COX-2 0
- HMGB1 0
- IL-1 1
- MMP-9 0
- STING 0
- EGFR 0
- SIRT1 0
- TP53 0
- YAP 0
- CTNNB1 0
- GPX4 0
- METTL3 0
- PD-1 0
- PDE4 0
- PTEN 0
- VEGF 0
- CCR5 0
- CFTR 0
- PD-L1 0
- PKM2 0
- ALK 1
- BDNF 0
- CD19 0
- CD38 0
- CXCR4 0
- FGFR 0
- FTO 0
- GIP 0
- HDAC 0
- IGF1R 0
- IL-23 0
- KIT 0
- MYC 0
- PCSK9 0
- SGLT2 0
- STK11 0
- ACE2 0
- APOE 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-ERC
Targeting airway lymphocytes in asthma and biologics treatment (TARGET-AIR-LAB)
European Commission (Horizon Europe) · HORIZON-CSA
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Evicting pathogenic type-2 resident memory T cells from the lungs of asthmatics (4GETasthma)
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Harnessing the potential of mRNA vaccination as a therapeutic strategy for asthma (mRNAsthma)
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Deciphering the biology of Multinucleated Alveolar Giant cells In Chronic inflammation (MAGIC)
European Commission (Horizon Europe) · HORIZON-ERC-POC
Maternal Interventions to Reduce Asthma: Targeting Novel Endotypes in Early Life (MIRA)
European Commission (Horizon Europe) · HORIZON-ERC
10 of 25 running projects, newest first. Listed amounts together: €58.2m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 18
- Organoids 2
- Mendelian Randomization Analysis 79
- Gene Expression Profiling 73
- Sequence Analysis, RNA 7
- Whole Genome Sequencing 1
- Exome Sequencing 2
- Proteomics 26
- Metabolomics 47
- Mass Spectrometry 16
- Flow Cytometry 18
- Immunohistochemistry 12
- Liquid Biopsy 1
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 1
- Magnetic Resonance Imaging 12
- Machine Learning 67
- Deep Learning 10
- Cohort Studies 249
- Genome-Wide Association Study 99
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.